Evidence map›Paper›PMID 40313388›Full record

ReviewPeerJ2025

Natural products as promising therapeutics for fine particulate matter-induced skin damage: a review of pre-clinical studies on skin inflammation and barrier dysfunction.

Saowanee Jeayeng, Jaturon Kwanthongdee, Ratima Jittreeprasert, Kankanich Runganantchai, Kalayaporn Naksavasdi, Rosarin Rirkkrai, Varisara Wongcharoenthavorn, Wiriya Mahikul, Anyamanee Chatsirisupachai

Abstract readReview
In one paragraph

Review in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Functional Features of Senescent Cells and Implications for Therapy.International journal of molecular sciences · 2025
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Saowanee Jeayeng *Department of Medical Science, School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.
Jaturon Kwanthongdee *Princess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Ratima JittreeprasertPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Kankanich RunganantchaiPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Kalayaporn NaksavasdiPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Rosarin RirkkraiPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Varisara WongcharoenthavornPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Wiriya MahikulPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Anyamanee ChatsirisupachaiPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Particulate matter less than 2.5 µm (PM2.5) is a significant air pollutant and is linked to an increased risk of health conditions, including skin diseases. The skin, as the first barrier and the largest organ, is primarily damaged by PM2.5 through different pathways. Several studies have shown that PM2.5 upregulates inflammatory responses through the excessive production of reactive oxygen species (ROS) and several inflammatory cytokines, leading to PM2.5-induced skin damage. The ROS/mitogen-activated protein kinase (MAPK) and Cyclooxygenase-2-Prostaglandin E2 (COX2/PGE2) inflammatory pathways are activated by free radical scavenging and phase II detoxification. Natural products have been suggested as therapeutic agents for mitigating PM2.5-induced skin damage. Objectives: We elaborate on the mechanisms of action of natural products and their functions as protectants against environmental skin diseases. This review highlights the optimal doses of natural products for clinical study, which may benefit dermatologists, molecular biologists, clinicians, and healthcare professionals in preventive and alternative medicine. Methodology: The available scientific literature published between 1999 and 2024 was searched using PubMed and Google Scholar. Multiple keywords related to the topic were used. Only 41 of the screened articles were chosen for this review, as they were the most relevant publications on the topic of the preventive advantages of natural products and specific pathways targeting PM2.5-induced skin injury. All relevant articles meeting the criteria of being original full articles and written in English were included. Results: This review summarized the natural products, including phenolic/polyphenolic compounds and flavonoids, that can act as anti-inflammatory and antioxidant agents by protecting the skin against oxidative stress, inhibiting enzymes that promote free radical formation, enhancing antioxidant enzyme activity, and reducing overall ROS formation. Several natural products have demonstrated efficacy in alleviating intracellular ROS, oxidative stress, mitochondrial dysfunction, autophagy, and apoptosis caused by PM2.5. In addition, phytochemical agents support the restoration of the skin wound healing process and muscle contraction impaired by environmental pollutants, such as PM2.5 and UV rays. Conclusion: This review highlights promising natural agents that can protect against environment-mediated health problems by focusing on their mechanisms of action. Particular emphasis is placed on antioxidant and anti-inflammatory compounds, including sulforaphane, hesperidin, quercetin, catechin, diphloroethohydroxycarmalol, resveratrol, and ginsenoside, which have become interesting candidates as nutraceuticals due to their potential to reduce reliance on conventional medicines. However, the low stability and bioavailability of natural products remain significant challenges to their clinical use; therefore, further research and development are warranted.

Indexed as

Biological ProductsParticulate MatterSkinSkin DiseasesAir PollutantsAnimalsHumansInflammationReactive Oxygen SpeciesAir PollutantsBiological ProductsParticulate MatterReactive Oxygen SpeciesAntioxidantInflammationNatural productsParticulate matter 2.5Skin barrier dysfunctionSkin damage

Identifiers

PMID40313388
PMCPMC12045276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.